Abstract
Ursolic acid (UA) is a pentacyclic terpenoid is usually found in the fruit peels and stem bark as secondary metabolites. UA has antiviral, antibacterial, and antiparasitic properties. UA has a wide spectrum of pharmacological activities against different infections. Because of the greatest antiviral and anti-inflammatory properties of UA, so it could be a plausible therapeutic herbal medicine in Covid-19 treatment. Covid-19 is a recent worldwide virulent disease pandemic due to severe acute respiratory coronavirus disease 2 (SARS-CoV-2). The pathogenesis of SARS-CoV-2 infection is related to the direct cytopathic effect and exaggerated immune response by which acute lung injury (ALI) and/or acute respiratory distress syndrome might be developed in critical cases. UA may inhibit main protease of SARS-CoV-2, and inhibits the interface flanked by SARS-CoV-2 viral proteins and its entry point commonly recognized as angiotensin converting enzyme 2 (ACE2). In addition, UA attenuates SARS-CoV-2-induced inflammatory reactions and oxidative stress.
Therefore, UA could avert SARS-CoV-2 infection from causing ALI. This opinion proposed that UA might be a potential candidate therapy against Covid-19 and can mitigate post-Covid-19 complications such as lung fibrosis. In this regards, forthcoming studies are reasonable to substantiate the therapeutic role of UA in Covid-19. However, taken into account that Covid-19 is yet to be investigating for further evaluations, therefore, clinical trials are recommended regarding use and dose of UA in Covid-19 treatment, as well as secondary effects.
Keywords: Ursolic acid, SARS-CoV-2, Covid-19
1. Background
Ursolic acid (UA) is a pentacyclic terpenoid with unique chemical structure (Fig. 1 ). UA is usually found in the fruit peels and stem bark as a secondary metabolites [1]. UA is used as a herb extract in the folk medicine for centuries as it found in leaves of rosemary, thyme, oregano, lavender, and hawthorn. UA is mainly used in the treatment and prevention of cancer through attenuation of proliferation and metastasis via modulation of metabolic pathways [2].
Fig. 1.
Chemical structure of ursolic acid.
Moreover, UA has been identified to be an important nutritional remedy prevents muscle atrophy, enhances glucose tolerance, and reduces hyperlipidemia-induced hepatic steatosis [3]. UA has antiviral, antibacterial, and antiparasitic properties, so it has a wide spectrum of pharmacological activities against different infections. As well, UA possesses anti-inflammatory and immune-modulating effects reducing inflammatory reactions in different immunological and autoimmune disorders [4].
The usual dose of UA that recommended in the treatment of various disorders is 300 mg/day. UA is usually used to increase muscle mass in athletics and reduce body weight mainly waist circumference and body mass index in obese subjects [41]. Moreover, UA is effective for treatment of different cardiovascular complications including heart failure, hypertension, and tachycardia by cardioprotective effects [7]. UA restore enzyme activity and prevents DNA damage of cardiomyocytes [7]. UA improves peripheral insulin sensitivity, inhibits development of insulin resistance with regulation of insulin secretion from pancreatic β-cells [16]. Therefore. UA is efficient in attenuation of diabetic nephropathy through mitigation of hyperglycemia-induced oxidative stress and inflammatory reaction in the kidneys [13]. In addition, UA has imperative action on the bone; it reduces the activity of osteoclasts and improves osteoblastic activity, thereby reducing risk for development of osteoporosis [42]. Despite of these potential benefits from use of UA, it may have some adverse effects including nausea, vomiting, abdominal pain, mild hematuria, skin rash and hypernatremia [45]. The most dangerous adverse effects from using of UA are dose-dependent hepatotoxicity [46] and promote vascular plaque formation and may increase risk of cardiovascular complications [47]. However, UA should not be an alternative for approved medical remedies. The most important pharmacological effects of UA on the clinic-pathological disorders are revised and summarized [Table 1 ].
Table 1.
The Pharmacological effects of Ursolic Acid.
The clinical-pathological findings | References |
---|---|
UA is a weak aromatase inhibitor may be used for infertility | Gnoatta et al. [5]. |
UA effective against obesity by decreasing white fat and increasing brown fat | Kunkel et al. [6]. |
Cardioprotective through anti-oxidant effect | Liobikas et al. [7]. |
Effective for treatment of multiple sclerosis by inhibiting Th17 | Zhang et al. [8]. |
Inhibits inflammation-induced cognitive dysfunction | Wang et al. [9]. |
Effective in the management of prostatic cancer | Meng et al. [10]. |
UA has anti-fibrotic effect through inhibition of NADPH oxidase | Hel et al. [11]. |
UA has anti-cancer effects through inhibition of signaling pathways | Lin et al. [12]. |
UA is effective for diabetic nephropathy | Ling et al. [13]. |
UA is effective for management of inflammatory bowel disease | Chun et al. [14]. |
UA is effective for management of inflammatory arthritis | Baek et al. [15]. |
UA has anti-diabetic effect by enhancing of insulin secretion and attenuation of insulin resistance | Castro et al. [16]. |
UA has significant antibacterial activity | Zhou et al. [17]. |
2. Mechanism of action of ursolic acid
The main mechanism of UA is related to the different pathways, one key mechanism is the ability of UA to inhibit mitogen activated protein kinase (MAPK) and mammalian target of rapamycin (mTOR), which involved in cell replications, and growths as well as different inflammatory pathways [43]. Besides, UA blocks cyclooxygenase-2 (COX-2) enzyme, which is important for development of inflammation [39] and nuclear factor kappa B (NF-κB), a signaling pathway vital in the regulation of immune response [34]. Likewise, UA attenuates oxidative stress through inhibition generation of reactive oxygen species (ROS) and potentiating of endogenous antioxidant capacity [44].
UA has important drug interaction effects, it inhibits organic anion transporter polypeptide 1 B1 (OATP1B1), which is important for transport of drugs like statins, valsartan, enalapril and bosentan from portal circulation into the liver to be metabolized [48]. In addition, UA blocks glucuronosyltransferase activity (UGT1A4), which is necessary for metabolism of lamotrigine [49].
3. Antiviral effects of ursolic acid
UA blocks human immune deficiency virus (HIV-1) protease, an essential aspartyl enzyme for synthesis of mature protein and polypeptide components of HIV-1 virion [18]. UA is also efficient against chronic hepatitis C (HCV) through inhibition of NS5B RNA-dependent polymerase and can be used alone or in combination with other anti-HCV drugs [19]. Furthermore, UA has anti-herpes activity by blocking early stages of herpes simplex virus adsorption and replication [20]. Tohme et al., confirmed that UA interferes with rotavirus replication cycle via suppression synthesis of VP6 and NSP2 viral proteins so; can be used as a new therapy against rotavirus infection [21]. Moreover, UA is a powerful and selective inhibitor of papilloma virus mainly human papilloma virus type 11 without cytotoxicity [22]. Song et al., observed that UA is powerful inhibitor of influenza virus (H5N1) entry [23]. Additionally, UA limits proliferation and spreads of enterovirus 71 (EV71) [24]. In vitro study revealed that UA reduces expression of human papilloma virus −18 (HPV-18) E6/E7 genes in HeLa cells; however expression of p53 did not change [25]. Similarly, a recent study by Chen et al., revealed that UA derivatives are effective against porcine reproductive and respiratory syndrome virus through direct inactivation of viral virion and replication [26].
From these findings, UA has broad-spectrum anti-viral activities, by which it reduces viral load and viral proliferation through interruption of viral replication cycle [27].
4. SARS-CoV-2 infection and ursolic acid
Because of the greatest antiviral and anti-inflammatory properties of UA, so it might be a plausible therapeutic herbal medicine in treating Covid-19, a recent worldwide virulent disease pandemic due to severe acute respiratory coronavirus disease 2 (SARS-CoV-2) [28]. The pathogenesis of SARS-CoV-2 infection is related to the direct cytopathic effect and exaggerated immune response by which acute lung injury (ALI) and/or acute respiratory distress syndrome might be developed in the critical cases [28]. Contemporary in silico and docking studies observed that UA may inhibit main protease of SARS-CoV-2 [29]. Subbaiyan et al., showed that UA also inhibits the interface flanked by SARS-CoV-2 viral proteins and its entry point commonly recognized as angiotensin converting enzyme 2 (ACE2) [30]. Thus, the anti-SARS-CoV-2 activity of UA increases the probability for using of UA in the treatment of Covid-19. Though, updated in vitro and ex-vivo experimental studies are recommended to determine the precise mechanism of anti-SARS-CoV-2 activity of UA.
In severe critical infections, overstated immune response and elevated pro-inflammatory cytokine level are linked with progression of ALI and/or ARDS [31]. Yang et al., experimental study in mice found that UA attenuates development of heat stress-induced-ALI [31]. This pulmoprotective effect of UA is might be through suppression release of inflammatory and pro-inflammatory cytokines mediated by activation of p38 mitogen-activated protein kinase (p38MAPK) [32]. Therefore, UA could avert SARS-CoV-2 infection from causing ALI through modulation of pro-inflammatory and inflammatory signaling pathways.
Interestingly, extravagant hypercytokinemia, which linked with development of cytokine storm in Covid-19, is mainly mediated through direct activation of p38MAPK and nuclear factor kappa B (NF-κB) [33]. It has been reported that UA can prevents the development of inflammation and oxidative stress by inhibiting of p38MAPK and NF-κB signaling pathways [34]. Likewise, UA could prevents activation of NLRP3 inflammasome during acute inflammatory reactions [34], thus it may reduce risk for development of cytokine storm mediated by NLRP3 inflammasome stimulation by SARS-CoV-2 [33]. Therefore, suppression of p38MAPK, NF-κB and NLRP3 inflammasome signaling pathways by UA might be a protective mechanism against exaggerated immune-induced ALI in Covid-19.
Extraordinarily, renin-angiotensin aldosterone system (RAAS) is extremely dysregulated during SARS-CoV-2 infection, characterized by elevation of angiotensin II (AngII) due to down-regulation of ACE2. AngII through angiotensin receptor type 1 (ATR1) induce the release of pro-inflammatory cytokines, activation of inflammatory signaling pathways, triggering of procoagulant cascades and development of ALI [35]. Ma et al., illustrated that UA may attenuate progress of inflammation, oxidative stress, and release of pro-inflammatory cytokines through down-regulation of AngII/AT1R signaling [36]. In this sense, controlling of AngII/AT1R signaling dysregulation during acute SARS-CoV-2 by the effect of UA could propose that UA may temper AngII-mediated ALI/ARDS.
Besides, UA may hamper the development of lung fibrosis through inhibition the activity and release of transforming growth factor beta (TGF-β) [37], which is over-activated in Covid-19 and linked with post-Covid-19 lung fibrosis and other life-threatening squeals [38]. So, prolong use of UA mainly in patients with severe Covid-19 may reduce risk for development of post-Covid-19 complications like lung fibrosis.
Also, UA inhibits the activity of COX-2 enzyme, which engaged with cell proliferation and malignant transformation [39]. COX-2 is triggered during SARS-CoV-2 infection, leading to lung inflammation and augmentation of fibro-proliferative response to the SARS-CoV-2-induced ALI [40]. Hence, UA may have a potential effect in the management of severe Covid-19 by inhibiting COX-2-induced lung inflammation.
The net-final effect of UA in SARS-CoV-2 infection is mediated through direct anti-SARS-CoV-2, anti-inflammatory effects, suppression of inflammatory signaling pathways inhibition and release of pro-inflammatory cytokines [Fig. 2 ].
Fig. 2.
The potential role of ursolic acid in the SARS-CoV-2 infection: () The inhibitory effect of ursolic acid.
5. Conclusion
These findings proposed that UA might be a potential candidate therapy against Covid-19 and can mitigate post-Covid-19 complications such as lung fibrosis. In this regards, forthcoming studies are reasonable to substantiate the therapeutic role of UA in Covid-19. However, taken into account that Covid-19 is yet to be investigating for further evaluations, therefore, clinical trials are recommended regarding use and dose of UA in Covid-19 treatment, as well as secondary effects. At present time, no recommendation can be made about UA, doses and time of use. Repurposing of approved anti-inflammatory drugs and investigate their efficacy against inflammatory signaling pathways, which are targeted by UA might of value in Covid-19 treatment.
We deeply acknowledge all medical staff members in College of Medicine, Al-Mustansiriyah University and head of Mustansiriyah University for their supports. There is no funding and grants to acknowledge.
Authorship
HMK performed study design and writing AIA performed critical review and preparation of the manuscripts. Both authors revised and approved the final proof.
Funding
This opinion paper had no funding.
Declaration of competing interest
The authors had no conflicts of interest to declare.
References
- 1.Liu J. Oleanolic acid and ursolic acid: research perspectives. J Ethnopharmacol. 2005 Aug 22;100(1–2):92–94. doi: 10.1016/j.jep.2005.05.024. [DOI] [PubMed] [Google Scholar]
- 2.Wang X., Zhang F., Yang L., Mei Y., Long H., Zhang X., et al. Ursolic acid inhibits proliferation and induces apoptosis of cancer cells in vitro and in vivo. J Biomed Biotechnol. 2011 Jan 1:2011. doi: 10.1155/2011/419343. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Calvani R., Landi F., Collamati A., Serafini E., Bernabei R., Marzetti E. Foods and Dietary Supplements in the Prevention and Treatment of Disease in Older Adults. 2015 Jan 1. Nutritional strategies against sarcopenia of aging: current evidence and future directions; pp. 231–238. [Google Scholar]
- 4.Hussain H., Green I.R., Ali I., Khan I.A., Ali Z., Al-Sadi A.M., et al. Ursolic acid derivatives for pharmaceutical use: a patent review (2012-2016) Expert Opin Ther Pat. 2017 Sep 2;27(9):1061–1072. doi: 10.1080/13543776.2017.1344219. [DOI] [PubMed] [Google Scholar]
- 5.Gnoatto S.C., Dassonville-Klimpt A., Da Nascimento S., Galéra P., Boumediene K., Gosmann G., et al. Evaluation of ursolic acid isolated from Ilex paraguariensis and derivatives on aromatase inhibition. Eur J Med Chem. 2008 Sep 1;43(9):1865–1877. doi: 10.1016/j.ejmech.2007.11.021. [DOI] [PubMed] [Google Scholar]
- 6.Kunkel S.D., Elmore C.J., Bongers K.S., Ebert S.M., Fox D.K., Dyle M.C., et al. Ursolic acid increases skeletal muscle and brown fat and decreases diet-induced obesity, glucose intolerance and fatty liver disease. PLoS One. 2012 Jun 20;7(6) doi: 10.1371/journal.pone.0039332. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Liobikas J., Majiene D., Trumbeckaite S., Kursvietiene L., Masteikova R., Kopustinskiene D.M., et al. Uncoupling and antioxidant effects of ursolic acid in isolated rat heart mitochondria. J Nat Prod. 2011 Jul 22;74(7):1640–1644. doi: 10.1021/np200060p. [DOI] [PubMed] [Google Scholar]
- 8.Zhang Y., Li X., Ciric B., Curtis M.T., Chen W.J., Rostami A., et al. A dual effect of ursolic acid to the treatment of multiple sclerosis through both immunomodulation and direct remyelination. Proc Natl Acad Sci Unit States Am. 2020 Apr 21;117(16):9082–9093. doi: 10.1073/pnas.2000208117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Wang Y.J., Lu J., Wu D.M., Zheng Z.H., Zheng Y.L., Wang X.H., et al. Ursolic acid attenuates lipopolysaccharide-induced cognitive deficits in mouse brain through suppressing p38/NF-κB mediated inflammatory pathways. Neurobiol Learn Mem. 2011 Sep 1;96(2):156–165. doi: 10.1016/j.nlm.2011.03.010. [DOI] [PubMed] [Google Scholar]
- 10.Meng Y., Lin Z.M., Ge N., Zhang D.L., Huang J., Kong F. Ursolic acid induces apoptosis of prostate cancer cells via the PI3K/Akt/mTOR pathway. Am J Chin Med. 2015 Oct 26;43(7):1471–1486. doi: 10.1142/S0192415X15500834. [DOI] [PubMed] [Google Scholar]
- 11.He Y., Li W., Li Y., Zhang S., Wang Y., Sun C. Ursolic acid increases glucose uptake through the PI3K signaling pathway in adipocytes. PLoS One. 2014 Oct 20;9(10) doi: 10.1371/journal.pone.0110711. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Lin J., Chen Y., Wei L., Hong Z., Sferra T.J., Peng J. Ursolic acid inhibits colorectal cancer angiogenesis through suppression of multiple signaling pathways. Int J Oncol. 2013 Nov 1;43(5):1666–1674. doi: 10.3892/ijo.2013.2101. [DOI] [PubMed] [Google Scholar]
- 13.Ling C., Jinping L., Xia L., Renyong Y. Ursolic acid provides kidney protection in diabetic rats. Curr Ther Res. 2013 Dec 1;75:59–63. doi: 10.1016/j.curtheres.2013.07.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Chun J., Lee C., Hwang S.W., Im J.P., Kim J.S. Ursolic acid inhibits nuclear factor-κB signaling in intestinal epithelial cells and macrophages, and attenuates experimental colitis in mice. Life Sci. 2014 Aug 6;110(1):23–34. doi: 10.1016/j.lfs.2014.06.018. [DOI] [PubMed] [Google Scholar]
- 15.Baek S.Y., Lee J., Lee D.G., Park M.K., Lee J., Kwok S.K., et al. Ursolic acid ameliorates autoimmune arthritis via suppression of Th17 and B cell differentiation. Acta Pharmacol Sin. 2014 Sep;35(9):1177–1187. doi: 10.1038/aps.2014.58. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Castro A.J., Frederico M.J., Cazarolli L.H., Mendes C.P., Bretanha L.C., Schmidt E.C., et al. The mechanism of action of ursolic acid as insulin secretagogue and insulinomimetic is mediated by cross-talk between calcium and kinases to regulate glucose balance. Biochim Biophys Acta Gen Subj. 2015 Jan 1;1850(1):51–61. doi: 10.1016/j.bbagen.2014.10.001. [DOI] [PubMed] [Google Scholar]
- 17.Zhou L., Ding Y., Chen W., Zhang P., Chen Y., Lv X. The in vitro study of ursolic acid and oleanolic acid inhibiting cariogenic microorganisms as well as biofilm. Oral Dis. 2013 Jul;19(5):494–500. doi: 10.1111/odi.12031. [DOI] [PubMed] [Google Scholar]
- 18.Akihisa T., Ogihara J., Kato J., Yasukawa K., Ukiya M., Yamanouchi S., et al. Inhibitory effects of triterpenoids and sterols on human immunodeficiency virus-1 reverse transcriptase. Lipids. 2001 May;36(5):507–512. doi: 10.1007/s11745-001-0750-4. [DOI] [PubMed] [Google Scholar]
- 19.Kong L., Li S., Liao Q., Zhang Y., Sun R., Zhu X., et al. Oleanolic acid and ursolic acid: novel hepatitis C virus antivirals that inhibit NS5B activity. Antivir Res. 2013 Apr 1;98(1):44–53. doi: 10.1016/j.antiviral.2013.02.003. [DOI] [PubMed] [Google Scholar]
- 20.Bag P., Chattopadhyay D., Mukherjee H., Ojha D., Mandal N., Sarkar M.C., et al. Anti-herpes virus activities of bioactive fraction and isolated pure constituent of Mallotus peltatus: an ethnomedicine from Andaman Islands. Virol J. 2012 Dec;9(1):1–2. doi: 10.1186/1743-422X-9-98. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Tohmé M.J., Giménez M.C., Peralta A., Colombo M.I., Delgui L.R. Ursolic acid: a novel antiviral compound inhibiting rotavirus infection in vitro. Int J Antimicrob Agents. 2019 Nov 1;54(5):601–609. doi: 10.1016/j.ijantimicag.2019.07.015. [DOI] [PubMed] [Google Scholar]
- 22.Kazakova O.B., Gul’nara V.G., Yamansarov E.Y., Tolstikov G.A. Betulin and ursolic acid synthetic derivatives as inhibitors of Papilloma virus. Bioorg Med Chem Lett. 2010 Jul 15;20(14):4088–4090. doi: 10.1016/j.bmcl.2010.05.083. [DOI] [PubMed] [Google Scholar]
- 23.Song G., Shen X., Li S., Li Y., Liu Y., Zheng Y., et al. Structure–activity relationships of 3-O-β-chacotriosyl ursolic acid derivatives as novel H5N1 entry inhibitors. Eur J Med Chem. 2015 Mar 26;93:431–442. doi: 10.1016/j.ejmech.2015.02.029. [DOI] [PubMed] [Google Scholar]
- 24.Wu K.X., Ng M.M., Chu J.J. Developments towards antiviral therapies against enterovirus 71. Drug Discov Today. 2010 Dec 1;15(23–24):1041–1051. doi: 10.1016/j.drudis.2010.10.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Yim E.K., Lee M.J., Lee K.H., Um S.J., Park J.S. Antiproliferative and antiviral mechanisms of ursolic acid and dexamethasone in cervical carcinoma cell lines. Int J Gynecol Cancer. 2006 Oct 1;16(6) doi: 10.1111/j.1525-1438.2006.00726.x. [DOI] [PubMed] [Google Scholar]
- 26.Chen Y., Li H., Wu L., Zhang M., Gao Y., Wang H., et al. Ursolic acid derivatives are potent inhibitors against porcine reproductive and respiratory syndrome virus. RSC Adv. 2020;10(38):22783–22796. doi: 10.1039/d0ra04070c. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Chiang L.C., Ng L.T., Cheng P.W., Chiang W., Lin C.C. Antiviral activities of extracts and selected pure constituents of Ocimum basilicum. Clin Exp Pharmacol Physiol. 2005 Oct;32(10):811–816. doi: 10.1111/j.1440-1681.2005.04270.x. [DOI] [PubMed] [Google Scholar]
- 28.Lugnier C., Al-Kuraishy H.M., Rousseau E. PDE4 inhibition as a therapeutic strategy for improvement of pulmonary dysfunctions in Covid-19 and cigarette smoking. Biochem Pharmacol. 2021 Jan 28;28:114431–114438. doi: 10.1016/j.bcp.2021.114431. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Shree P., Mishra P., Selvaraj C., Singh S.K., Chaube R., Garg N., et al. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants–Withania somnifera (Ashwagandha), Tinospora cordifolia (Giloy) and Ocimum sanctum (Tulsi)–a molecular docking study. J Biomol Struct Dyn. 2020 Aug 26:1–4. doi: 10.1080/07391102.2020.1810778. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Subbaiyan A., Ravichandran K., Singh S.V., Sankar M., Thomas P., Dhama K., et al. In silico molecular docking analysis targeting SARS-CoV-2 spike protein and selected herbal constituents. J Pure Appl Microbiol. 2020 May 27;14(suppl 1):989–998. [Google Scholar]
- 31.Yang Y., Li C., Liu N., Wang M., Zhou X., Kim I.H., et al. Ursolic acid alleviates heat stress-induced lung injury by regulating endoplasmic reticulum stress signaling in mice. J Nutr Biochem. 2021 Mar 1;89:108557. doi: 10.1016/j.jnutbio.2020.108557. [DOI] [PubMed] [Google Scholar]
- 32.Pitaloka D.A., Cooper A.M., Artarini A.A., Damayanti S., Sukandar E.Y. Regulation of mitogen-activated protein kinase signaling pathway and proinflammatory cytokines by ursolic acid in murine macrophages infected with Mycobacterium avium. Infect Dis Rep. 2020 Jul;12(S1):5–10. doi: 10.4081/idr.2020.8717. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Al-Kuraishy H.M., Al-Gareeb A.I., Faidah H., Al-Maiahy T.J., Cruz-Martins N., Batiha G.E. The looming effects of estrogen in Covid-19: a Rocky Rollout. Front Nutr. 2021;8 doi: 10.3389/fnut.2021.649128. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Ma J.Q., Ding J., Zhang L., Liu C.M. Ursolic acid protects mouse liver against CCl4-induced oxidative stress and inflammation by the MAPK/NF-κB pathway. Environ Toxicol Pharmacol. 2014 May 1;37(3):975–983. doi: 10.1016/j.etap.2014.03.011. [DOI] [PubMed] [Google Scholar]
- 35.Al-Kuraishy H.M., Hussien N.R., Al-Naimi M.S., Al-Buhadily A.K., Al-Gareeb A.I., Lungnier C. Renin–Angiotensin system and fibrinolytic pathway in COVID-19: one-way skepticism. Biomed Biotechnol Res J. 2020 Aug 1;4(5):33. [Google Scholar]
- 36.Ma T.K., Xu L., Lu L.X., Cao X., Li X., Li L.L., et al. Ursolic acid treatment alleviates diabetic kidney injury by regulating the ARAP1/AT1R signaling pathway. Diabetes, Metab Syndrome Obes Targets Ther. 2019;12:2597. doi: 10.2147/DMSO.S222323. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Lin L., Hou G., Han D., Kang J., Wang Q. Ursolic acid protected lung of rats from damage induced by cigarette smoke extract. Front Pharmacol. 2019 Jun 20;10:700. doi: 10.3389/fphar.2019.00700. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Hu Z.J., Xu J., Yin J.M., Li L., Hou W., Zhang L.L., et al. Lower circulating interferon-gamma is a risk factor for lung fibrosis in COVID-19 patients. Front Immunol. 2020 Sep 29;11:2348. doi: 10.3389/fimmu.2020.585647. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Liu L., Zhang J., Li M., Zhang X., Zhang J., Li Z., et al. Inhibition of HepG2 cell proliferation by ursolic acid and polysaccharides via the downregulation of cyclooxygenase-2. Mol Med Rep. 2014 Jun 1;9(6):2505–2511. doi: 10.3892/mmr.2014.2059. [DOI] [PubMed] [Google Scholar]
- 40.Chen J.S., Alfajaro M.M., Wei J., Chow R.D., Filler R.B., Eisenbarth S.C., et al. Cyclooxgenase-2 is induced by SARS-CoV-2 infection but does not affect viral entry or replication. bioRxiv. 2020 Jan 1 doi: 10.1101/2020.09.24.312769. [DOI] [Google Scholar]
- 41.Kunkel S.D., Elmore C.J., Bongers K.S., Ebert S.M., Fox D.K., Dyle M.C., et al. Ursolic acid increases skeletal muscle and brown fat and decreases diet-induced obesity, glucose intolerance and fatty liver disease. PLoS One. 2012 Jun 20;7(6) doi: 10.1371/journal.pone.0039332. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Zheng H., Feng H., Zhang W., Han Y., Zhao W. Targeting autophagy by natural product Ursolic acid for prevention and treatment of osteoporosis. Toxicol Appl Pharmacol. 2020 Dec 15;409:115271. doi: 10.1016/j.taap.2020.115271. [DOI] [PubMed] [Google Scholar]
- 43.Luo J., Hu Y.L., Wang H. Ursolic acid inhibits breast cancer growth by inhibiting proliferation, inducing autophagy and apoptosis, and suppressing inflammatory responses via the PI3K/AKT and NF-κB signaling pathways in vitro. Exp Ther Med. 2017 Oct 1;14(4):3623–3631. doi: 10.3892/etm.2017.4965. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Wang X.T., Gong Y., Zhou B., Yang J.J., Cheng Y., Zhao J.G., et al. Ursolic acid ameliorates oxidative stress, inflammation and fibrosis in diabetic cardiomyopathy rats. Biomed Pharmacother. 2018 Jan 1;97:1461–1467. doi: 10.1016/j.biopha.2017.11.032. [DOI] [PubMed] [Google Scholar]
- 45.Zhu Z., Qian Z., Yan Z., Zhao C., Wang H., Ying G. A phase I pharmacokinetic study of ursolic acid nanoliposomes in healthy volunteers and patients with advanced solid tumors. Int J Nanomed. 2013;8:129–136. doi: 10.2147/IJN.S38271. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Wang X.H., Zhou S.Y., Qian Z.Z., Zhang H.L., Qiu L.H., Song Z., et al. Evaluation of toxicity and single-dose pharmacokinetics of intravenous ursolic acid liposomes in healthy adult volunteers and patients with advanced solid tumors. Expet Opin Drug Metabol Toxicol. 2013 Feb;9(2):117–125. doi: 10.1517/17425255.2013.738667. [DOI] [PubMed] [Google Scholar]
- 47.Messner B., Zeller I., Ploner C., Frotschnig S., Ringer T., Steinacher-Nigisch A., et al. Ursolic acid causes DNA-damage, p53-mediated, mitochondria- and caspase-dependent human endothelial cell apoptosis, and accelerates atherosclerotic plaque formation in vivo. Atherosclerosis. 2011 Dec;219(2):402–408. doi: 10.1016/j.atherosclerosis.2011.05.025. [DOI] [PubMed] [Google Scholar]
- 48.Hua W.J., Hua W.X., Nan F.Y., Jiang W.A., Yan C. The influence of herbal medicine ursolic acid on the uptake of rosuvastatin mediated by OATP1B1∗1a and ∗5. Eur J Drug Metab Pharmacokinet. 2014 Sep;39(3):221–230. doi: 10.1007/s13318-014-0187-8. Epub 2014 Apr 16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Wang Q., Liang M., Dong Y., Yun W., Qiu F., Zhao L., et al. Effects of UGT1A4 genetic polymorphisms on serum lamotrigine concentrations in Chinese children with epilepsy. Drug Metabol Pharmacokinet. 2015 Jun;30(3):209–213. doi: 10.1016/j.dmpk.2014.12.007. [DOI] [PubMed] [Google Scholar]